Open Access Rheumatology : Research and Reviews
Overview
Open Access Rheumatology : Research and Reviews is a scientific journal, published by Dove Medical Press since 2009 in English. The journal's country of origin is New Zealand and its primary focus area is rheumatology.
Details
Details
Abbr.
Open Access Rheumatol
Publisher
Dove Medical Press
Start
2009
End
Continuing
e-ISSN
1179-156X
Country
New Zealand
Language
English
Specialty
Rheumatology
Metrics
Metrics
h-index / Ranks: 11752
23
SJR / Ranks: 8635
519
CiteScore / Ranks: 6878
3.90
Recent Articles
1.
Al-Homood I, Almaghlouth I, Asiri A, Hamdy H, Alhammad A, Mustafa A, et al.
Open Access Rheumatol
. 2025 Feb;
17:33-45.
PMID: 39973976
Purpose: To describe intravenous (IV) belimumab's clinical effectiveness in patients with systemic lupus erythematosus (SLE) in real-world practice in Saudi Arabia. Patients And Methods: This retrospective, observational OBSErve study (GSK...
2.
Koreli U, Torun E, Adas M
Open Access Rheumatol
. 2025 Feb;
17:25-32.
PMID: 39931075
Introduction: Patients with fever of unknown origin (FUO) and/or inflammation of unknown origin (IUO) challenge clinicians in daily rheumatology practice. Positron emission tomography-computed tomography (PET/CT) is being used in the...
3.
Frezgi O, Berhane A, Ghebrewelde G, Tekie H, Kiflezgi T, Mohamedsied A, et al.
Open Access Rheumatol
. 2025 Feb;
17:13-24.
PMID: 39912116
Background: Chikungunya fever is a mosquito-borne viral illness that has re-emerged as an important global concern. Persistent arthralgia following chikungunya fever is common and requires advanced pharmacological interventions as pain...
4.
Wright G, Zueger P, Copley-Merriman C, Khan S, Costello J, Krumbach A, et al.
Open Access Rheumatol
. 2025 Jan;
17():1-12.
PMID: 39811715
Objective: Underserved populations are often at risk of experiencing systematic healthcare disparities. Existing disparities in care access, quality of care received, and treatment outcomes among patients with rheumatic disease are...
5.
Santamaria Torroba A, Acin Lazaro M, Gomez-Rubio E, Coronel Granado P
Open Access Rheumatol
. 2024 Dec;
16:157-163.
PMID: 39677564
Purpose: This study aims to evaluate the real-world efficacy and safety of intra-articular (IA) hyaluronic acid (HA) injections in patients with hip osteoarthritis (OA). Given the increasing burden of hip...
6.
Umukundwa R, Akimana E, Nsanzimana V, Mapira H, Musarurwa C
Open Access Rheumatol
. 2024 Dec;
16:147-156.
PMID: 39618700
Background: Hyperuricemia, a precursor to gout, and rheumatoid factor positivity (RF), an autoantibody linked to rheumatoid arthritis (RA), but also present in various conditions and healthy adults, hold significant health...
7.
Sghiri R, Ben Hassine H, Ghozzi M, El Amri N, Baccouche K, Sarraj R, et al.
Open Access Rheumatol
. 2024 Jul;
16:137-145.
PMID: 39045423
Purpose: FRAX is a tool used for evaluation of risk of fracture in RA and non-RA patients and to identify those eligible for intervention. One of the limitations of FRAX...
8.
Pope J, Finckh A, Silva-Fernandez L, Mandl P, Fan H, Rivas J, et al.
Open Access Rheumatol
. 2024 Jun;
16:115-126.
PMID: 38883150
Purpose: To evaluate the characteristics, efficacy, and retention of tofacitinib monotherapy in patients with rheumatoid arthritis using data from randomized controlled trials (RCTs) and real-world data (RWD). Patients And Methods:...
9.
Otsuji N, Sugiyama K, Owada T, Arifuku H, Koyama K, Hirata H, et al.
Open Access Rheumatol
. 2024 Jun;
16:127-135.
PMID: 38883149
Purpose: The prognosis of rheumatoid arthritis (RA) with interstitial lung disease (ILD) is particularly poor. Although drugs that do not contribute to the progression of ILD should be used in...
10.